Searched for
AKUMS DRUGS
Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities extended gains for a third straight session, with Sensex and Nifty rising on optimism over the Iran-US peace framework and ...- Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...
- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities witnessed sharp swings before ending lower amid expiry-day volatility and rising geopolitical concerns. Profit booking in b...
- Ahead of Market: 10 things that will decide stock market action on ThursdayIndian equities lost momentum after a positive start, with Nifty closing lower and broader markets declining sharply. Investor caution ahea...
- Market Trading Guide: Akums Drugs among 4 stock recommendations for ThursdayDomestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Buy Akums Drugs & Pharmaceuticals, target price Rs 710: ICICI SecuritiesICICI Securities maintains a Buy call on Akums Drugs & Pharmaceuticals, setting a target price of Rs 710. The company reported a consolidat...
- Buy Akums Drugs & Pharmaceuticals, target price Rs 710: ICICI SecuritiesICICI Securities has given a buy call for Akums Drugs & Pharmaceuticals with a target price of Rs 710, citing profitable growth potential. ...
- Akum Drugs shares tumble 5% despite posting Rs 60 crore Q1 profitAkum Drugs Share Price: Akum Drugs and Pharmaceuticals' shares dropped 5% to Rs 895 despite reporting a Rs 60 crore net profit for the June...
- Akums Drugs and Pharma shares jump 8% post listing. Should you buy, sell or hold?Akums Drugs and Pharmaceuticals saw its shares rise 8% to Rs 784.6 on its debut, despite a strong subscription rate of 63.44 times. Analyst...
- Akums Drugs and Pharma shares list at 7% premium over issue priceAkums Drugs and Pharmaceuticals' shares began trading at Rs 725, a 6.8% premium over the issue price of Rs 679, after an IPO that was subsc...
- Akums Drugs and Pharma shares to list on Tuesday. Here's what GMP suggestsAkums Drugs and Pharmaceuticals will debut on Tuesday. The stock, with a GMP of Rs 140, is expected to list at a 21% premium over the upper...
- Akums Drugs & Pharma IPO share allotment to be finalised today: Check status, GMP, listing date and other detailsAkums Drugs & Pharma share allotment has been finalised. Shares will be out on August 6. The IPO was subscribed 63.5 times. Proceeds will a...
- Akums Drugs and Pharma IPO: Check subscription on Day 3, GMP and other detailsNon-institutional investors subscribed 22.8 times, followed by retail investors, whose category was booked 13.8 times. The part reserved fo...
- Akums Drugs and Pharma IPO: Check subscription on Day 2, GMP and other detailsIn the unlisted market, shares of the company are currently commanding a premium of 26% over the IPO price, with GMP of Rs 175. The IPO its...
- Akums Drugs and Pharma IPO opens for subscription. Should you bid?Akums Drugs IPO Review GMP, Subs: Akums Drugs and Pharmaceuticals' IPO, valued at Rs 1,857 crore, closed on August 1. The issue included Rs...
- Akums Drugs and Pharma IPO opens tomorrow: Price band, GMP among 10 things to know before subscribingAkums Drugs and Pharma's IPO, open from July 30 to August 1, targets raising Rs 1857 crore. The company specializes in pharmaceutical devel...
- Akums Drugs and Pharma IPO: Co to raise ₹1,857 crore at price band of Rs 646-679/share; issue opens on July 30Akums Drugs and Pharma IPO: Akum Drugs and Pharmaceuticals set a price band of Rs 646 to Rs 679 per share for its IPO, aiming to raise Rs 1...
- Akums Drugs files draft IPO papers with Sebi; eyes Rs 680 cr via fresh issueThe company is looking to raise Rs 136 crore through a pre-IPO placement. If such placement is undertaken, then fresh issue size will be re...
- HC grants relief to Troikaa in patent case; restrains two firms from selling Dynapar injectionsHC has granted a temporary relief to Troikaa restraining two pharma companies from making & selling the patented versions of diclofenac inj...
Load More
